Skip to main content

Kathleen M. Neuzil, MD, MPH, FIDSA

Director, Center for Vaccine Development

Academic Title:

Professor

Primary Appointment:

Medicine

Secondary Appointment(s):

Pediatrics

Administrative Title:

Director, Center for Vaccine Development; Deputy Director, Institutes for Global Health; Division Head, Geographic Medicine; Interim Director of Institute of Global Health

Additional Title:

Professor and Director, Center for Vaccine Development, Deputy Director, Institute for Global Health

Location:

HSF I 480G

Phone (Primary):

410-706-4946

Fax:

410-706-6205

Education and Training

  • University of Maryland (summa cum laude), B.S., Zoology, 1983
  • Johns Hopkins University School of Medicine (Alpha Omega Alpha (AOA) Honor Medical Society), 1987
  • Residency, Vanderbilt University School of Medicine, Internal Medicine, 1987-1991
  • Fellowship, Vanderbilt University School of Medicine, Infectious Diseases, 1991-1994
  • Vanderbilt University School of Medicine, M.P.H., 1998

Biosketch

Dr. Neuzil is one of the world’s most influential research scientists and advocates in the area of vaccine development and policy. She is deputy director of the University of Maryland School of Medicine’s groundbreaking new Institute for Global Health, as well as director of the Center for Vaccine Development (CVD). Throughout her career, she has conducted clinical and epidemiologic studies on vaccine-preventable diseases, including work on influenza and rotavirus, that have informed domestic and international vaccine policy.

From 2005-2015, Dr. Neuzil held leadership positions at PATH, an international nonprofit global health organization based in Seattle. At PATH, Dr. Neuzil led large multidisciplinary teams to design and implement pivotal vaccine trials and operational research, and to translate these findings into policy, access and delivery of vaccines in the world’s poorest countries. Dr. Neuzil's research capabilities are complimented by nearly 20 years of involvement in domestic and international policy, including membership on the Centers for Disease Control’s Advisory Committee on Immunization Practices as well as the Pandemic Influenza Task Force for the Infectious Disease Society of America.

Additionally, she has served as a technical advisor to the World Health Organization on diarrheal diseases, maternal immunization and vaccine safety. Dr. Neuzil has contributed more than 160 scientific publications on vaccines and infectious diseases.

Research/Clinical Keywords

Global public health, infectious diseases, vaccine access and delivery, vaccine safety, rotavirus, pandemic influenza, immunization, maternal immunization, diarrheal diseases, maternal child health, reproductive health, sexually transmitted diseases

Highlighted Publications

Brooks WA, Zaman K, Lewis K, Ortiz JR, Goswami D, Fesser J, Sharmeen AT, Nahar K, Rahman M, Rahman MZ, Barin B, Yunus M, Fry M, Bresee J, Azim T, Neuzil KM. Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: A randomized controlled trial. Lancet Glob Health. 2016 Oct 13. doi: http://dx.doi.org/10.1016/S2214-109X(16)30200-5

Victor JC, Lewis K, Diallo A, Niang M, Diarra B, Dia N, Ortiz JR, Widdowson MA, Feser J, Hoagland R, Emery SL, Lafond KE, Neuzil, KM. Efficacy of live attenuated influenza vaccine among children in Senegal: A randomised trial. Lancet Glob Health. 2016 Oct 13. doi: http://dx.doi.org/10.1016/S2214-109X(16)30201-7

Zaman K, Fleming JA, Victor JC, Yunus M, Bari TI, Azim T, Rahman M, Mowla SM, Bellini WJ, McNeal M, Icenogle JP, Lopman B, Parashar U, Cortese MM, Steele AD, Neuzil KM. Non-interference of rotavirus vaccine with measles-rubella vaccine at 9months and improvements in anti-rotavirus immunity: A randomized trial. J Infect Dis. 2016 Jun 1;213(11):1686-93.

Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, Adrian PV, van Niekerk N, Treurnicht F, Ortiz JR, Venter M, Violari A,Neuzil KM, Simões EA, Klugman KP, Nunes MC, Maternal Flu Trial (Matflu) Team. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014 Sept 4;371(10):918-31.

Neuzil KM, Canh do G, Thiem VD, Janmohamed A, Huong VM, Tang Y, Diep NT, Tsu V, LaMontagne DS.  Immunogenicity and reactogenicity of alternative schedules of HPV vaccine in Vietnam: A cluster randomized noninferiority trial. JAMA. 2011 April 13;305(14):1424-31.

Additional Publication Citations

Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson KF, Ansah NA, Levine MM, Lewis K, Coia ML, Attah-Poku M, Ojwando J, Rivers SB, Victor JC, Nyambane G, Hodgson A, Schödel F, Ciarlet M, Neuzil KM. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: A randomised, double-blind, placebo-controlled trial. Lancet. 2010 Aug 21;376(9741):606-14.

Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, Han HH, Neuzil KM. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362(4):289-98.

Research Interests

Dr. Neuzil's research focuses on vaccine development and introduction in under-developed areas. She works on a variety of vaccines, including influenza, rotavirus, and RSV, as well as on cross-cutting issues such as maternal immunization, optimizing vaccine use, and overcoming barriers to sustainable vaccine uptake in low resource settings. Her capabilities range from epidemiology and clinical trials to expertise in vaccine research and development, partnerships with vaccine manufacturers, and domestic and international health policy.

Awards and Affiliations

  • Chair, Pandemic Influenza Task Force, Infectious Disease Society of America (IDSA) 2005-2008; Member 2008-present
  • Member, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, 2006-2010 (Chair, Influenza Vaccine Working Group, 2008-2010; Chair, Vaccines in Pregnancy Working Group 2006-2008)
  • PATH Vision Award in the Advancing Global Health Category for the Cervical Cancer Prevention Project, 2009
  • Joseph E. Smadel lectureship, IDSA Annual Meeting, Vancouver, CA, 2010

Grants and Contracts

Kathleen Neuzil, M.D., M.P.H., FIDSA (PI)
OPP1116751
10/01/14-11/30/19
Bill & Melinda Gates Foundation
Data Management and Analysis and Publication Plan for Rotavirus Vaccine

Kathleen Neuzil, M.D., M.P.H., FIDSA (Mali site co- PI)
10017561
2016-1018
Emory University (sponsor Bill & Melinda Gates Foundation)           
Child Health and Mortality Prevention Surveillance (CHAMPS) Network

  • Participate in a long-term network of high-quality sites to collect robust and standardized primary data with the overriding objective of identifying and tracking the preventable causes of childhood death globally.

Kathleen Neuzil, M.D., M.P.H., FIDSA (PI)
16-0024
04/28/16-01/31/17
National Institutes of Health (NIH)
Vaccine and Treatment Evaluation Units (VTEU) 
Pertussis Protocol

Kathleen Neuzil, M.D., M.P.H., FIDSA (PI)
OPP1147728
04/20/16-10/31/16
Bill & Melinda Gates Foundation
10th African Rotavirus Symposium

  • Support the 10th iteration of a biannual symposium for dissemination of information on rotavirus disease epidemiology, clinical developments, and rotavirus vaccine introductions in Africa.

In the News

Professional Activity

Dr. Neuzil's extensive experience in domestic and international policy includes membership on the CDC's Advisory Committee on Immunization Practices and the Pandemic Influenza Task Force for the Infectious Disease Society of America. She has worked with the World Health Organization as a technical advisor on diarrheal diseases, a member of the Strategic Advisory Group of Experts rotavirus vaccine working group, and a member of the Global Advisory Committee on Vaccine Safety working group on the safety of vaccines in pregnancy. She currently chairs the steering committee for the CDC-sponsored Ebola vaccine trial in Sierra Leone.

Previous Positions

  • Chair, Pandemic Influenza Task Force, Infectious Disease Society of America (IDSA) 2005-2008; Member 2008-present
  • Member, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, 2006-2010 (Chair, Influenza Vaccine Working Group, 2008-2010; Chair, Vaccines in Pregnancy Working Group 2006-2008)
  • PATH Vision Award in the Advancing Global Health Category for the Cervical Cancer Prevention Project, 2009
  • Joseph E. Smadel lectureship, IDSA Annual Meeting, Vancouver, CA, 2010